Recent research has highlighted a growing connection between vitamin D levels and long-term brain health, suggesting that maintaining adequate levels of this nutrient in midlife may play a role in reducing the risk of cognitive decline decades later. As populations age globally, understanding modifiable risk factors for neurodegenerative conditions like Alzheimer’s disease has become a priority for public health officials and researchers alike.
Vitamin D, often associated with bone health, is increasingly recognized for its influence on neurological function. Scientific investigations have revealed that vitamin D receptors are present throughout the brain, particularly in areas involved in memory and cognition. This has prompted studies into whether vitamin D deficiency could contribute to the development of dementia, including Alzheimer’s disease, through mechanisms such as inflammation, oxidative stress, and impaired clearance of toxic protein aggregates like amyloid-beta.
A 2022 longitudinal study published in Alzheimer’s & Dementia examined the relationship between vitamin D levels in both blood and brain tissue and cognitive outcomes in older adults. Conducted as part of the Rush Memory and Aging Project, the research followed 290 cognitively healthy participants for over a decade, measuring serum levels of 25-hydroxyvitamin D3 and assessing cognitive function annually using a battery of 19 tests. After death, researchers analyzed brain tissue for vitamin D metabolites and neuropathological signs of dementia. The study found that although blood levels of vitamin D have been linked to cognitive performance, the relationship between brain-specific vitamin D concentrations and cognition remains less clear, warranting further investigation.
More recent findings from a large-scale prospective study using UK Biobank data, published in June 2025, provide stronger evidence for a direct association between vitamin D status and dementia risk. The study included over 269,000 participants and tracked them for an average of 13.6 years. Researchers identified that 18.3% of participants had vitamin D deficiency (defined as serum 25-hydroxyvitamin D levels below 30 nmol/L), while 34% had insufficiency (levels between 30–50 nmol/L). Over the follow-up period, 7,087 cases of dementia were recorded, including 3,616 cases of Alzheimer’s disease and 1,815 cases of vascular dementia.
The analysis revealed a dose-dependent relationship: individuals with severe vitamin D deficiency had a 25% higher risk of developing any form of dementia compared to those with sufficient levels. For Alzheimer’s disease specifically, the increased risk was 19%, and for vascular dementia, it was 24%. Even mild insufficiency was associated with an 11% higher risk of dementia 10% for Alzheimer’s, and 15% for vascular dementia. Researchers noted that vitamin D may support brain health by promoting the clearance of amyloid plaques and offering neuroprotection against neuronal damage.
Additional support comes from a 10-year U.S.-based study involving over 12,000 participants with an average age of 71 at enrollment, none of whom had a dementia diagnosis at the start. Conducted by researchers from the University of Exeter and published in Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, the study found that vitamin D supplementation was associated with a 40% reduction in dementia incidence. Notably, the protective effect was more pronounced in women and in individuals who do not carry the APOEε4 gene, a well-known genetic risk factor for Alzheimer’s disease. Of the 2,696 participants who developed dementia during the follow-up, 75% had not taken vitamin D supplements prior to their diagnosis.
These findings suggest that maintaining sufficient vitamin D levels — potentially through diet, sunlight exposure, or supplementation — could be a accessible strategy for supporting long-term brain health. However, experts caution that while observational studies show strong associations, they do not prove causation. Randomized controlled trials are still needed to determine whether increasing vitamin D intake directly prevents or delays the onset of dementia.
Current guidelines from health organizations recommend maintaining serum 25-hydroxyvitamin D levels of at least 50 nmol/L for overall health, though some experts argue for higher thresholds — such as 75 nmol/L or more — for optimal immune and neurological function. Natural sources of vitamin D include fatty fish (like salmon and mackerel), egg yolks, and fortified foods such as milk and cereals. Sunlight exposure remains a primary source, though factors like skin pigmentation, geographic location, season, and sunscreen use can affect synthesis.
For individuals concerned about their vitamin D status, a simple blood test can measure 25-hydroxyvitamin D levels. Healthcare providers can interpret results and recommend appropriate interventions, which may include dietary changes or supplementation, particularly for those at higher risk of deficiency — such as older adults, people with limited sun exposure, or those with certain medical conditions affecting nutrient absorption.
As research continues to unfold, the potential role of vitamin D in dementia prevention remains an active and promising area of investigation. While no single nutrient can guarantee protection against complex conditions like Alzheimer’s disease, maintaining adequate vitamin D levels represents one piece of a broader puzzle that includes physical activity, cognitive engagement, social connection, and management of cardiovascular risk factors.
Stay informed about the latest developments in brain health and nutrition by following updates from trusted medical journals and public health agencies. Readers are encouraged to share their experiences and questions in the comments below and to spread awareness by sharing this article with others who may benefit from this information.